Out of the Closet Designer Wins HBO Max Craftopia Episode OutBuro lgbt professional entreprenuer networking online community gay lesbian transgender queer bisexual nonbinary

‘Out of the Closet’ Designer Wins HBO Max ‘Craftopia’ Episode

Edgar Eiotown, a respected artist and the longtime and award-winning visual display coordinator for AIDS Healthcare Foundation’s ‘Out of the Closet’ thrift store chain, lands first place on HBO Max’s ‘Craftopia’ program, Season 2, Episode 2 (“Bow-Wow Ween”)

LOS ANGELES–(BUSINESS WIRE)–#OTC–The longtime and award-winning visual display coordinator for AIDS Healthcare Foundation’s (AHF) Out of the Closet thrift store chain, has won first place in a crafting and design competition in a special episode of HBO Max’s innovative reality program, “Craftopia.”


Edgar Eiotown, a respected artist who has designed windows and other visual displays for AHF’s 21 ‘Out of the Closet’ stores for over 20 years, triumphed over two other “Craftopia” contestants in a special Halloween-themed design competition that was the focus of Episode 2, Season 2 of the HBO Max program titled “Bow-Wow Ween.” Eiotown learned of his victory just prior to HBO Max’s streaming of the episode, which began streaming last week (October 7).

“For over twenty years, Edgar has worked his special magic with our Out of the Closet windows and visual displays harnessing his keen artistic sensibility and real-world practical design skills in his work helping to raise funds and awareness about AHF and our mission delivering HIV/AIDS prevention, care and services,” said Jonathan Kreuyer, General Manager of AHF’s Out of the Closet Store chain. “I am thrilled to learn of his win here, a well-deserved recognition of his unique talent and vision.”

In the “Bow-Wow Ween” episode of “Craftopia,” Eiotown went up against two other artists, all of whom were given two crafting assignments. The first was to create a Halloween costume for a dog (which another contestant prevailed at), and second, to create a piece of wearable art representing the concept of ‘split personality.’ Eiotown handily won this portion of the competition, creating an elaborate black, red, yellow and white costume featuring a Venetian- or Kabuki-style face mask designed with two intricately painted and distinct halves. To underscore the concept of split personality and heighten the impact of his artistic vision in his presentation to the judges, Eiotown’s mask also opened at one point right down the middle, top-to-bottom across the nose line, to reveal that he had made his face up and painted it identically as the mask—however, each half of his painted face was now the reverse of the beautifully handcrafted mask.

“Edgar: on behalf of all your Out of the Closet and AHF colleagues, we offer our congratulations and are so proud of you for your spectacular work on HBO Max’s Craftopia,” said AHF President Michael Weinstein. “Out of the Closet remains a powerhouse brand and not-so-secret weapon for AHF. Your visual artistry over the years on our behalf has been equally remarkable, adding fun to the shopping experience while helping us honor our mission of service. It is particularly amazing that you could do that much beautiful and intricate work under that kind of time pressure on your Craftopia episode. You are much more than a craftsman you are an artist. Bravo!”

In addition to his work for Out of the Closet, Eiotown is indeed also an artist whose work can be viewed at his eponymous website: www.eiotown.com. Eiotown marked his 20th year working for Out of the Closet this past April. AHF’s Out of the Closet thrift store chain celebrated its 30th anniversary last October. The OTC stores—all of which Eiotown oversees for visual display—consists of 21 stores in seven states (with another outlet set to open in San Diego at the end of October).

Over the years Eiotown’s design work for Out of the Closet has been officially honored with awards and recognitions in Los Angeles, Chicago and Dallas.

Out of the Closet Thrift stores provide people a fun, cause-worthy place to shop and donate gently used goods in support of the fight against HIV/AIDS. Many Out of the Closet Thrift Stores make HIV testing easy with fixed-site testing in stores. Many Out of the Closet sites are also connected to an AHF Pharmacy, providing a convenient one-stop experience for clients to shop and pick up their medications.

HBO Max

Instagram: @HBOMax

Twitter: @HBOMax

Facebook: facebook.com/HBOMax
www.hbomax.com
#Craftopia

#CraftopiaOnMax

Edgar Eiotown

Instagram: @eiotown

www.eiotown.com
#eiotown

Out of the Closet Thrift Stores

Instagram: @outofthecloset

Twitter: @outofthecloset

Facebook: facebook.com/OutoftheClosetThriftStores
www.outofthecloset.org
#outofthecloset

#OTC

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us @aidshealthcare.

Contacts

Ged Kenslea, Senior Director, Communications, AHF

+1.323.791.5526 [cell] [email protected]

OutBuro lgbt professional entreprenuer networking online community gay lesbian transgender queer bisexual nonbinary 2

AHF Praises President Biden’s Pick for New PEPFAR Chief

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS care provider operating in 45 countries, praised today President Biden’s decision to nominate John Nkengasong to lead the US President’s Emergency Plan for AIDS Relief (PEPFAR).

Nkengasong currently serves as the Director of the Africa Centres for Disease Control and Prevention (ACDC). Before joining ACDC as its inaugural director, he served as an acting deputy director at the US CDC Center for Global Health. Nkengasong is a virologist by training and holds a dual US and Cameroonian citizenship.

“We believe Dr. Nkengasong is well suited to lead PEPFAR because his tireless efforts in fighting COVID-19 as the head of ACDC are widely praised across Africa. As a virologist, he understands both the HIV and the COVID-19 pandemics, and has the requisite managerial and scientific credentials to successfully lead PEPFAR,” said AHF Africa Bureau Chief Dr. Penninah Iutung. “We hope the US Senate will fully support Dr. Nkengasong’s nomination and move quickly to confirm his appointment. To-date PEPFAR has saved millions of lives, most of them across Africa, and during the ongoing pandemic it is also providing indispensable COVID-19 relief. With Dr. Nkengasong at the helm, PEPFAR will continue its legacy of lifesaving humanitarian work funded by the generosity of the American people.”

Congress will soon consider whether to reauthorize PEPFAR for another five years. AHF has always been a strong supporter of PEPFAR and has repeatedly advocated for its reauthorization in previous rounds.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1.323.308.1833 work +1.323.791.5526 mobile

[email protected]

Denys Nazarov, Director of Global Policy &

Communications, AHF

+1 323.308.1829

[email protected]

OutBuro lgbt professional entreprenuer networking online community gay lesbian transgender queer bisexual nonbinary 2

Statement from the Board of Directors: The Black AIDS Institute Announces Interim CEO

Interim CEO will serve alongside new Managing Director and Expert Consultants

NEW YORK, Sept. 23, 2021 /PRNewswire/ — The Board of Directors of the Black AIDS Institute (BAI) is pleased to announce the appointment of Toni Newman as its Interim Chief Executive Officer and Dr. Kemal M. Atkins as Managing Director to help fortify BAI’s infrastructure and round out the organization’s stellar leadership team.

In addition, BAI has engaged Ms. Pat Bass and Mr. Chris Bates – two internationally recognized experts who pioneered HIV/AIDS prevention, education, and treatment programs – to assess BAI’s current capabilities and mission.

Ms. Newman is currently the Interim Executive Director at LYRIC – a non-profit in San Francisco, California that focuses on advancing the community and creating social change for lesbian, gay, bisexual, transgender, queer, and questioning (LGBTQQ) youth through education, career training, and health advocacy. She oversees the budget, programs, and community outreach for LYRIC. Ms. Newman is a distinguished Faculty Member at the Transgender Strategy Center in Los Angeles, where she advises non-profit organizations on engagement with transgender and non-conforming communities. In addition, she is the Chair of the Board of Directors for TransCanWork based in Los Angeles. Ms. Newman has a wealth of knowledge in non-profit management, budget and finance, and human resources and operations. We’re excited that she has agreed to serve as our Interim CEO as we continue implementing our transition plan to find a permanent, innovative executive staff leader.

Dr. Atkins has been engaged to help further build infrastructure and management processes at BAI. Dr. Atkins, who will serve as a consultant on a temporary basis, has an extensive background in higher education and non-profit leadership where his expertise in crisis management, such as leading institutional responses to the COVID-19 pandemic, and expertise in building national wellness health models will provide much-needed program direction for BAI.

Ms. Bass’s work in the field of HIV/AIDS prevention truly extraordinary. As one of the architects of the Ryan White CARES Act – the largest federally funded program for people living with HIV/AIDS, she helped pave the way for modern treatments to prevent the spread and contraction of the virus. Mr. Bates also has a distinguished career in HIV prevention policy – having served as the Executive Director on the Presidential Advisory Council on AIDS and Director of the Office of AIDS Policy under President Barack Obama. Together they will oversee a comprehensive review of BAI’s program efficacy, contributions, and impact in the field of HIV/AIDS prevention and provide data that informs BAI’s mission as the organization continues to refine.

Ms. Newman, Dr. Atkins, Ms. Bass and Mr. Bates will work alongside Jami Cox and Wendell Miller as we continue to deploy our substantial resources, forward-looking vision, and human capital in the fight to end the HIV epidemic in Black communities and improve the health and quality of life for Black people living with and vulnerable to acquiring HIV/AIDS across the country.

The work of BAI is as important today as it ever has been, and we’re so proud of our incredibly talented and dedicated team that understands what is at stake for the Black community impacted by HIV and committed to ending this epidemic. Please join us in welcoming these accomplished leaders to our team. And thank you for continuing to support BAI and our entire staff across our networks.

Contact:
Tori Campbell
(332) 207-1473
[email protected]

SOURCE Black AIDS Institute

Queer News Tonight Health Q&A with Dr. Grossman OutBuro LGBT professional entrepreneur online networking community gay lesbian bisexual transgender nonbinary 2

Queer News Tonight Health Q&A with Dr. Grossman

“Welcome to Queer News Tonight’s Q&A on LGBTQ+ Health & Pandemic. Since February 2020 this segment has been unique in America answering you LGBTQ+ community questions about our unique health needs. We are proud to have Queer News Tonight Health Anchor Dr. Howard Grossman. He is an American pioneer in HIV/AIDS medical treatment and was the Executive Director of the American Academy of HIV Medicine. He is a nationally recognized medical expert and proud member of our LGBTQ+ community. Good evening Dr. Grossman. Before we move into viewer questions, what are your thoughts on this week’s health news for our community? Let’s jump right into tonight’s questions.

A new study shows the Moderna vaccine produces twice as many antibodies as Pfizer. If I got the Pfizer vaccine, should I get a Moderna booster?

Cam Newton, one of the top Quarterbacks in the NFL, was cut from the Patriots roster for being unvaccinated. Will more sports teams do this?

A judge in Ohio ordered a hospital to treat a patient with Ivermectin. What are your thoughts on this?

That is tonight’s Queer News Tonight Q&A on LGBTQ+ Health & Pandemic. We are here every Tuesday with Dr. Howard Grossman to answer your questions. Need medical assistance? We encourage you to contact Dr. Howard Grossman is here in Wilton Manors and all across South Florida. Thank you Howard. “

?️ We need your support! Become a patron: https://www.Patreon.com/QNewsTonight

? Missed our most recent video? Catch up here: http://bit.do/QNT-New
———-

Want to hear more news that affects the #LGBTQ Community?
Tune in daily for Queer News Tonight LIVE at 8pm Eastern. Catch up on-demand on YouTube. If LGBT Content is important to you, remember to subscribe and ring the bell: http://bit.do/subQNews

Facebook: https://www.facebook.com/QueerNewsTonight/
Twitter: https://twitter.com/qnewstonight
Subscribe to our Emails: http://eepurl.com/ghS0cn

————-

Queer News Tonight is a product of Happening Out Television Network, a collection of powerful brands that deliver diverse and engaging content. Sister shows include:
– It’s Happening OUT , the World’s Most Popular LIVE Gay Television Show. www.YouTube.com/ItsHappeningOut
– TRANSlation, the first show BY the Transgender community FOR Trans allies. www.YouTube.com/TRANSlationTalk

OutBuro lgbt professional entreprenuer networking online community gay lesbian transgender queer bisexual nonbinary 2

City of Hope and Griffith University Researchers Use Novel Method to Block HIV in Mice

Scientists developed an anti-HIV protein called ZPAMt that can be delivered to affected areas using exosomes, nanosized parts of cells able to reach difficult-to-access areas of the body, such as the brain.

DUARTE, Calif.–(BUSINESS WIRE)–Researchers at City of Hope, a world-renowned research and treatment organization for cancer and diabetes, and Menzies Health Institute Queensland at Griffith University have developed a novel anti-HIV protein that suppressed HIV levels in the bone marrow, spleen, and brain of mice and prevented the virus from replicating in those regions, according to a new study published in Nature Communications today.


Their research demonstrates that scientists could engineer nanosized parts of cells called exosomes to carry therapeutic cargo to hard-to-reach places, including the nearly impenetrable blood-brain barrier. This innovative delivery system paves the way for a future where it’s conceivable that engineered exosomes could carry cargo that either suppress infectious diseases or restructure genetic material so that pathogens are rendered harmless.

“This innovative technology could become a viable way to deliver therapies not only for HIV but also for other diseases, including ones that affect the brain, such as Alzheimer’s and Parkinson’s,” said Professor Kevin Morris, Ph.D. from City of Hope’s Center for Gene Therapy and Griffith University’s School of Pharmacy and Medical Sciences. Morris is senior author of the new study.

Human immunodeficiency virus attacks cells that help the body fight infection, making an individual more vulnerable to other infections and diseases. Many researchers believe one way to cure HIV is to “block and lock” the disease in a process that obstructs the ability of the virus to replicate and locks it in a dormant state.

“The ZPAMt HIV protein repressor we developed is packaged into exosome nanoparticles and can enter cells where it epigenetically silences HIV,” Morris said. “We show that these nanoparticles can systemically ‘block and lock’ HIV expression. This is the first time that block and lock has been successfully delivered to treat HIV in vivo in the brain.”

HIV can enter the human body in a dormant-like state; it is able to hide from the body’s immune system and evade treatments. Then, it can reactivate later. HIV hiding in the brain is especially difficult to treat because of the blood-brain barrier, which prevents both toxins and therapies from entering the brain.

Currently, there is no cure for HIV, so once someone contracts it, he or she will have it for life. An estimated 1.19 million people in the United States had HIV at the end of 2019, according to the Centers for Disease Control and Prevention.

The research was supported by the National Institutes of Health’s National Institute of Mental Health (R01 113407-01).

About City of Hope

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona. Translational Genomics Research Institute (TGen) became a part of City of Hope in 2016. AccessHopeTM, a subsidiary launched in 2019, serves employers and their health care partners by providing access to NCI-designated cancer center expertise. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.

About Griffith University

Griffith University is a comprehensive research-intensive university ranked in the top 2% of universities globally with 50,000 students spanning six campuses in South East Queensland, Australia. Its research excellence, innovative teaching and learning practices, and strong industry ties makes it one of the leading providers of higher education in the Asia–Pacific.

Contacts

Zen Vuong

626-409-9367

[email protected]

OutBuro lgbt professional entreprenuer networking online community gay lesbian transgender queer bisexual nonbinary

Magellan Rx Management’s AIDS Drug Assistance Program Center of Excellence Expands Program That Significantly Improves Medication Adherence and Quality of Care for Patients with HIV

PHOENIX–(BUSINESS WIRE)–Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN) has expanded Navigate Whole Health to include the AIDS Drug Assistance Program (ADAP) that applies an innovative and comprehensive approach to managing the quality of care for persons receiving treatment for HIV. Through the program, clinical pharmacists partner with providers to manage complex cases by promoting best-practices for HIV treatment and closing care gaps. The Navigate Whole Health ADAP program also supports participating ADAPs in meeting Health Resources & Services Administration (HRSA) performance measures.

“Navigate Whole Health ADAP offers a unique opportunity to support participating ADAP customers, providers and their members by concentrating on HIV/AIDS treatments, comorbid chronic diseases, behavioral health conditions, and social determinants that interfere with outcomes,” said Caroline Carney, MD, chief medical officer, Magellan Health. “We are using data science to tailor interventions to deliver the right supports to prevent interruptions in therapy and address behavioral healthcare, including depression and substance abuse.”

Adherence to antiretroviral therapy (ART) is critical to reducing viral load, transmission, and resistance. For most patients, nearly perfect (>95 percent) adherence is necessary to achieve optimal viral suppression and clinical success. However, the national average rate of adherence to ART is around 70 percent, and the total annual unadjusted costs per patient for non-adherence to HIV ART therapy ranged from $16,957 to $30,068.1,2

The Navigate Whole Health ADAP pilot program was conducted for nine months. An analysis of the first three months of intervention shows a 26.7 percent increase in HIV/ART medication adherence in six months post intervention. This program also addresses behavioral concerns, like depression, and achieved a 60 percent increase in members being adherent to their antidepressant medication adherence. “It is particularly encouraging to note that 100% of the recommendations made by Magellan clinical team were accepted by prescribers,” says Astha Chopra, vice president, clinical effectiveness, Magellan Health.

ADAP Center of Excellence

Magellan Rx established a national ADAP Center of Excellence (COE) with a dedicated call center to provide timely service and continuity of care. The dedicated ADAP team provides a multi-faceted approach to State ADAP programs across the country with a best-in class operating paradigm to help improve patient outcomes and prevent HIV. Navigate ADAP is one of the ways the Magellan Rx ADAP COE helps improve clinical quality for ADAP members.

“With over three decades of experience in serving some of the largest state ADAP programs, our Magellan team is deeply invested in the national effort to combat AIDS and the HIV epidemic through education, awareness, research and access to medications for those living with the disease. We invested in the Center of Excellence to leverage significant expertise on behalf of all our ADAP customers and their members. This program is one of many examples of our commitment to this work.” Meredith Delk, general manager and senior vice president, government markets, Magellan Rx Management.

About Magellan Rx Management: Magellan Rx Management, a division of Magellan Health, Inc., is shaping the future of pharmacy. As a next-generation pharmacy organization, we deliver meaningful solutions to the people we serve. As pioneers in specialty drug management, industry leaders in Medicaid pharmacy programs and disruptors in pharmacy benefit management, we partner with our customers and members to deliver a best-in-class healthcare experience.

About Magellan Health: Magellan Health, Inc., is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan’s customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

1.

Machtinger EL, Bangsberg DR. Adherence to HIV Antiretroviral Therapy. HIV in Site Knowledge Base Chapter; May. 2005. [Accessed on 2021 Mar 16]. Content Reviewed; January 2006. http://hivinsite.ucsf.edu/InSite?page=kb-03-02-09.

2.

Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. Published 2018 Jan 21. doi:10.1136/bmjopen-2017-016982

(MGLN-GEN)

Contacts

Media: Lilly Ackley, [email protected], (860) 507-1923

Investor: Darren Lehrich, [email protected], (860) 507-1814

OutBuro lgbt professional entreprenuer networking online community gay lesbian transgender queer bisexual nonbinary

AHF Dumbfounded by Gilead’s Claim of No AIDS Stigma Today

In recent legal filing in lawsuits over one of its HIV/AIDS medications that causes permanent and potentially deadly damage to the kidneys and bones, Gilead’s white shoe law firm, Sidley Austin, stumbles as it claims “…there is no shame or stigma …” associated with the disease today

At the same time its lawyers deny AIDS stigma, NBC News reported that Gilead itself funded a newly released study that found half of Americans “… said they’d feel uncomfortable with a HIV-positive medical professional, 42 percent were uncomfortable with a hair stylist or a barber living with the virus, and a third (34 percent) said they were uncomfortable with an HIV-positive teacher.”

LOS ANGELES–(BUSINESS WIRE)–Today, AIDS Healthcare Foundation announced that in a recent legal filing in personal injury lawsuits against Gilead Sciences Inc. seeking to hold the Bay Area drug maker accountable over one of its HIV/AIDS medications that allegedly causes permanent damage to the kidneys and bones, lawyers for Gilead claimed that “no shame or stigma” remains associated with HIV/AIDS today as they sought to reverse a judicial order denying Gilead access to AHF’s patient and client mailing lists.

In an August 9, 2021 filing in the Superior Court of California County of San Francisco (Case No. CJC-19-005043) seeking reconsideration of the Court’s Recommended Order No. 19 (Motions to Quash, and to Modify, Deposition Subpoena For Production of Business Records to AIDS Healthcare Foundation), lawyers for Sidley Austin, Gilead’s law firm, twice asserted there is no longer stigma associated with HIV or AIDS today, writing:

  • “Support for the HIV/AIDS community is not even stigmatized in today’s society,” (pleading, P #5, lines 19 & 20), and
  • “Further, there is no shame or stigma associated with supporting those affected by HIV/AIDS…” (pleading, P #9, lines 17 & 18).

At nearly the same time Gilead’s lawyers dubiously claimed that no HIV/AIDS stigma remains today, a new study undertaken by the LGBTQ advocacy group GLAAD and the Southern AIDS Coalition found that half of Americans “… said they’d feel uncomfortable with a HIV-positive medical professional, 42 percent were uncomfortable with a hair stylist or a barber living with the virus, and a third (34 percent) said they were uncomfortable with an HIV-positive teacher.” According to NBC News, the study, “The State of HIV Stigma 2021”, was published and widely reported on August 26, 2021.

NBC News also reported that Gilead funded the study.

Gilead’s assertions denying the existence of stigma surrounding HIV/AIDS today came about in its response to multiple personal injury lawsuits by patients taking Gilead medications. The lawsuits focus on Gilead’s failure to rectify a known defect in its tenofovir disoproxil fumarate (TDF) drug formulation, knowing that a safer alternate, tenofovir alafenamide (TAF) existed—in Gilead’s own laboratories—and for its failure to warn patients of the damaging side effects of TDF as well as Gilead’s active misrepresentation of TDF’s efficacy and risks. AHF supported many of the plaintiffs’ lawsuits, which likely led to Gilead’s discovery requests for its mailing lists.

Gilead’s zeal to maintain and maximize its corporate profits came at the expense of the health and wellbeing of its customers who were prescribed and taking TDF. According to earlier pleadings in the cases, the company knew as far back as 2001 from its own studies and other research that TDF was, ‘…highly toxic in the doses prescribed and risked permanent and possibly fatal damage to the kidneys and bones.’

“It’s official, according to Gilead: there is no longer any stigma around AIDS today,” said Michael Weinstein, president of AHF. “I suppose that means Gilead wasted a lot of money on its recent—and disheartening—GLAAD/Southern AIDS Coalition study documenting the ongoing and severe stigma around HIV and AIDS. Perhaps Gilead should instead spend its energy developing a drug to treat the willful blindness associated with its overwhelming greed. They make billions of dollars harming HIV/AIDS patients when they knew they had a better, less toxic drug sitting on the shelf. Now, they declare AIDS stigma no longer exists. Gilead, what astounding arrogance—and greed!”

About AHF

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare

Contacts

Ged Kenslea, Senior Director, Communications, AHF

+1.323.791.5526 mobile

[email protected]

Gilead counterfeit versions HIV meds found in US OutBuro LGBTQ professional entrepreneur online networking community lesbian bisexual transgender nonbinary

Gilead warns that counterfeit versions of its HIV meds are being found in US

U.S. pharmacies are selling counterfeit versions of HIV medication, according to the biopharmaceutical company Gilead Sciences. Specifically, Gilead warned that knock-off versions of its Biktarvy and Descovy medications have circulated through pharmacies due to unauthorized distributors. Both medications are used to treat people living with HIV. Descovy is also used as pre-exposure prophylaxis (PrEP) to prevent HIV-negative people from contracting the virus. The company is working with the U.S. Food and Drug Administration, pharmacies and other legal authorities to track down the culprits and remove the counterfeit meds from the market. Gilead said the counterfeit and tampered medicines can “bring serious and sometimes life-threatening health risks to individuals.”

?️ We need your support! Become a patron: https://www.Patreon.com/QNewsTonight

? Missed our most recent video? Catch up here: http://bit.do/QNT-New

———–

Want to hear more news that affects the #LGBTQ Community?
Tune in daily for Queer News Tonight LIVE at 8pm Eastern. Catch up on-demand on YouTube. If LGBT Content is important to you, remember to subscribe and ring the bell: http://bit.do/subQNews

Facebook: https://www.facebook.com/QueerNewsTonight/
Twitter: https://twitter.com/qnewstonight
Subscribe to our Emails: http://eepurl.com/ghS0cn

————-

Queer News Tonight is a product of Happening Out Television Network, a collection of powerful brands that deliver diverse and engaging content. Sister shows include:
– It’s Happening OUT , the World’s Most Popular LIVE Gay Television Show. www.YouTube.com/ItsHappeningOut
– TRANSlation, the first show BY the Transgender community FOR Trans allies. www.YouTube.com/TRANSlationTalk

Tori Cooper Black Trans HIV Council OutBuro LGBTQ professional entrepreneur online networking community gay lesbian bisexual transgender nonbinary

Meet Tori Cooper, the 1st Black trans woman on the presidential HIV council

Tori Cooper is the first black transgender woman to be appointed to the White House Presidential HIV Council. She said the first time she used her voice as an advocate was about 20 years ago when she worked on a Center for Disease Control (CDC) prevention program called “Sister to Sister”. She and another transgender advocate adapted the HIV Risk Reduction program to meet the unique needs of trans women. Cooper, now the Director of Community Engagement for the Human Rights Campaign Transgender Justice Initiative was recently appointed to the Presidential advisory council on HIV/AIDS which was created in 1995 to provide the federal government with advice and policy recommendations on the prevention and cure of HIV/AIDS. She brings her 30 years of experience in the field to the position but she also brings her voice as a black transgender woman.

?️ We need your support! Become a patron: https://www.Patreon.com/QNewsTonight

? Missed our most recent video? Catch up here: http://bit.do/QNT-New
———-

Want to hear more news that affects the #LGBTQ Community?
Tune in daily for Queer News Tonight LIVE at 8pm Eastern. Catch up on-demand on YouTube. If LGBT Content is important to you, remember to subscribe and ring the bell: http://bit.do/subQNews

Facebook: https://www.facebook.com/QueerNewsTonight/
Twitter: https://twitter.com/qnewstonight
Subscribe to our Emails: http://eepurl.com/ghS0cn

————-

Queer News Tonight is a product of Happening Out Television Network, a collection of powerful brands that deliver diverse and engaging content. Sister shows include:
– It’s Happening OUT , the World’s Most Popular LIVE Gay Television Show. www.YouTube.com/ItsHappeningOut
– TRANSlation, the first show BY the Transgender community FOR Trans allies. www.YouTube.com/TRANSlationTalk

OutBuro lgbt professional entreprenuer networking online community gay lesbian transgender queer bisexual nonbinary

AHF: ‘Providence Journal’ Rejects Ad Skewering CVS’s PBM Abuse

AIDS organization’s ‘Corporate Vampires Suck’ advocacy ad had already run in nearly half-a-dozen print and online new outlets nationwide, but was rejected last week by CVS’s home state newspaper, the ‘Providence Journal’

AHF ad targets CVS, the sixth largest corporation in the world, for its anti-competitive behavior, notably, buying up health plans like Aetna, and then forcing patients—including HIV patients, who often rely on specialty services from their pharmacists—to obtain their lifesaving medications by mail order or drop shipment

LOS ANGELES–(BUSINESS WIRE)–#StopCVSNow–After AIDS Healthcare Foundation (AHF) launched a new national advocacy and ad campaign to take on health and pharmacy giant CVS over its anti-competitive business model and practices, it learned late last week that the ‘Providence Journal’—CVS’s home state daily newspaper—was rejecting AHF’s ad. CVS, the sixth largest corporation in the world, is headquartered in nearby Woonsocket, RI. A version of the ad ran in today’s Boston Sunday Globe on page A3.


The advocacy campaign and ad, ‘CVS: Corporate Vampires Suck’ (https://ahf.org/stop-cvs), targets CVS over its fierce anti-competitive behavior, specifically regarding its refusal to allow patients any choice in their pharmacy services. CVS’s currently forces most of its health plan patients from providers like Aetna—which CVS purchased for $69 billion in cash and stock in 2018—to obtain their lifesaving medications by mail order or drop shipment.

AHF’s ‘CVS: Corporate Vampires Suck’ campaign kicked off last month, with a full-page, full-color ad that ran in daily and weekly newspapers across the country with most ads landing Sunday, July 11. The ad also ran in the weekly ‘Houston Defender’ (Thursday, July 8). The Sunday papers include the Ft. Lauderdale ‘Sun Sentinel,’ ‘Houston Chronicle,’ and the ‘Chicago Defender’ (online). The ads are being complemented by a radio campaign, social media and a legislative call-to-action urging viewers and readers to contact their legislators asking them to help fight back against CVS’s monopolistic and anti-competitive behavior.

AHF intended to run the ad this week in the ‘Providence Journal’ and had been communicating back and forth with the paper’s advertising department regarding suggested possible changes or edits to the ad. Some changes were incorporated by AHF: a change to the parody CVS logo and some softening of the ad copy. However, after making some initial changes suggested by the ‘Providence Journal,’ the paper’s ad reps then advised AHF the ad could not run. They also refused to inform AHF what else might need to be changed or altered to clear the ad for publication. The ‘Providence Journal’ is the oldest continuously published daily newspaper in the United States.

“While we are disappointed that the ‘Providence Journal’ will not run our ‘Corporate Vampires Suck’ advocacy ad, we are not entirely surprised. It’s the hometown paper of CVS, which also runs multipage ad circulars dozens of Sundays every year in the paper and in most major newspapers across the country,” said Michael Weinstein president of AHF. “But make no bones about it. CVS remains a major threat to public health. It has been buying up health plans for billions and forcing clients—including HIV/AIDS patients—to use CVS’s mail order services, harming patients and fragmenting their care in the process. Patients are suffering and small pharmacies are being squeezed, with many, being put out of business. That’s why we put some real fangs into this advocacy campaign—we need the public’s help to fight back against CVS’s ‘corporate vampires.’”

AHF’s ‘CVS: Corporate Vampires Suck’ campaign will run until September. For more information about this campaign to fight back against CVS and pharmacy benefit managers (PBMs) who are putting their profit ahead of patient health, please visit: https://ahf.org/stop-cvs

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.5 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us @aidshealthcare.

Contacts

Ged Kenslea, Senior Director, Communications, AHF +1.323.791.5526 [cell] [email protected]
John Hassell, National Director of Advocacy, AHF +1.202.774.4854 [cell] [email protected]